Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial, tell me about this news in (https://www.manilatimes.net/2026/09/29/tmt-newswire/globenewswire/cyprumeds-oral-delivery-technology-advances-to-clinical-stage-as-msd-initiates-phase-i-trial/2434770)

Cyprumed’s oral delivery technology has officially entered the clinical stage as MSD initiated a Phase I clinical trial. This trial evaluates a proprietary drug candidate formulated using Cyprumed’s oral tablet technology, marking the first time one of Cyprumed’s technology programs has advanced into human clinical development. This major milestone also triggers a financial payment to Cyprumed under the companies’ existing collaboration agreement.

Cyprumed GmbH focuses on transforming peptide therapeutics by providing easy-to-manufacture, patient-friendly oral dosage forms, shifting traditional delivery methods toward more accessible patient care.